BioRestorative Therapies, Inc. reports positive data for its Phase 2 BRTX-100 Chronic Back Pain Trial, ending Q3 in a strong financial position. 340Bwell presents cutting-edge research at international conferences, focusing on optimizing STD clinic resources. Renowned economist Jim Rickards forecasts 'America's Comeback' under a new Trump administration, emphasizing energy policy and nuclear technology. ESTHELIVE introduces a new standard in skincare, focusing on 'wrinkle rehabilitation' with advanced ingredients for youthful, radiant skin.
